Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 21 entries
Sorted by: Best Match Show Resources per page
Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma.

Cancer immunology, immunotherapy : CII

Sun L, Mu L, Zhou J, Tang W, Zhang L, Xie S, Chen J, Wang J.
PMID: 33993366
Cancer Immunol Immunother. 2022 Jan;71(1):25-38. doi: 10.1007/s00262-021-02957-w. Epub 2021 May 16.

BACKGROUND: Tumor-infiltrating CD8 cells and expression of programmed cell death ligand 1 (PD-L1) are immune checkpoint markers in patients with hepatocellular carcinoma (HCC). We aimed to determine the ability of preoperative gadoxetic acid-enhanced magnetic resonance imaging (MRI) findings to...

Cite
Sun L, Mu L, Zhou J, et al. Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma. Cancer Immunol Immunother. 2021;71(1):25-38doi: 10.1007/s00262-021-02957-w.
Sun, L., Mu, L., Zhou, J., Tang, W., Zhang, L., Xie, S., Chen, J., & Wang, J. (2022). Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma. Cancer immunology, immunotherapy : CII, 71(1), 25-38. https://doi.org/10.1007/s00262-021-02957-w
Sun, Lin, et al. "Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma." Cancer immunology, immunotherapy : CII vol. 71,1 (2022): 25-38. doi: https://doi.org/10.1007/s00262-021-02957-w
Sun L, Mu L, Zhou J, Tang W, Zhang L, Xie S, Chen J, Wang J. Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma. Cancer Immunol Immunother. 2022 Jan;71(1):25-38. doi: 10.1007/s00262-021-02957-w. Epub 2021 May 16. PMID: 33993366.
Copy Download .nbib Format: NLM
Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma.

Cancer immunology, immunotherapy : CII

Sun L, Mu L, Zhou J, Tang W, Zhang L, Xie S, Chen J, Wang J.
PMID: 33993366
Cancer Immunol Immunother. 2021 May 16; doi: 10.1007/s00262-021-02957-w. Epub 2021 May 16.

BACKGROUND: Tumor-infiltrating CD8 cells and expression of programmed cell death ligand 1 (PD-L1) are immune checkpoint markers in patients with hepatocellular carcinoma (HCC). We aimed to determine the ability of preoperative gadoxetic acid-enhanced magnetic resonance imaging (MRI) findings to...

Cite
Sun L, Mu L, Zhou J, et al. Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma. Cancer Immunol Immunother. 2021;doi: 10.1007/s00262-021-02957-w.
Sun, L., Mu, L., Zhou, J., Tang, W., Zhang, L., Xie, S., Chen, J., & Wang, J. (2021). Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma. Cancer immunology, immunotherapy : CII, . https://doi.org/10.1007/s00262-021-02957-w
Sun, Lin, et al. "Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma." Cancer immunology, immunotherapy : CII vol. (2021). doi: https://doi.org/10.1007/s00262-021-02957-w
Sun L, Mu L, Zhou J, Tang W, Zhang L, Xie S, Chen J, Wang J. Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma. Cancer Immunol Immunother. 2021 May 16; doi: 10.1007/s00262-021-02957-w. Epub 2021 May 16. PMID: 33993366.
Copy Download .nbib Format: NLM
Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer.

Korean journal of radiology

Hwang JA, Min JH, Kim SH, Choi SY, Lee JE, Moon JY.
PMID: 35029076
Korean J Radiol. 2022 Jan 04; doi: 10.3348/kjr.2021.0407. Epub 2022 Jan 04.

OBJECTIVE: This study aimed to determine a factor for predicting suboptimal image quality of the hepatobiliary phase (HBP) of gadoxetic acid-enhanced MRI in patients with extrahepatic bile duct (EHD) cancer before MRI examination.MATERIALS AND METHODS: We retrospectively evaluated 259...

Cite
Hwang JA, Min JH, Kim SH, et al. Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer. Korean J Radiol. 2022;doi: 10.3348/kjr.2021.0407.
Hwang, J. A., Min, J. H., Kim, S. H., Choi, S. Y., Lee, J. E., & Moon, J. Y. (2022). Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer. Korean journal of radiology, . https://doi.org/10.3348/kjr.2021.0407
Hwang, Jeong Ah, et al. "Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer." Korean journal of radiology vol. (2022). doi: https://doi.org/10.3348/kjr.2021.0407
Hwang JA, Min JH, Kim SH, Choi SY, Lee JE, Moon JY. Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer. Korean J Radiol. 2022 Jan 04; doi: 10.3348/kjr.2021.0407. Epub 2022 Jan 04. PMID: 35029076.
Copy Download .nbib Format: NLM
Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma.

Cancer immunology, immunotherapy : CII

Sun L, Mu L, Zhou J, Tang W, Zhang L, Xie S, Chen J, Wang J.
PMID: 33993366
Cancer Immunol Immunother. 2022 Jan;71(1):25-38. doi: 10.1007/s00262-021-02957-w. Epub 2021 May 16.

BACKGROUND: Tumor-infiltrating CD8 cells and expression of programmed cell death ligand 1 (PD-L1) are immune checkpoint markers in patients with hepatocellular carcinoma (HCC). We aimed to determine the ability of preoperative gadoxetic acid-enhanced magnetic resonance imaging (MRI) findings to...

Cite
Sun L, Mu L, Zhou J, et al. Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma. Cancer Immunol Immunother. 2021;71(1):25-38doi: 10.1007/s00262-021-02957-w.
Sun, L., Mu, L., Zhou, J., Tang, W., Zhang, L., Xie, S., Chen, J., & Wang, J. (2022). Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma. Cancer immunology, immunotherapy : CII, 71(1), 25-38. https://doi.org/10.1007/s00262-021-02957-w
Sun, Lin, et al. "Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma." Cancer immunology, immunotherapy : CII vol. 71,1 (2022): 25-38. doi: https://doi.org/10.1007/s00262-021-02957-w
Sun L, Mu L, Zhou J, Tang W, Zhang L, Xie S, Chen J, Wang J. Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma. Cancer Immunol Immunother. 2022 Jan;71(1):25-38. doi: 10.1007/s00262-021-02957-w. Epub 2021 May 16. PMID: 33993366.
Copy Download .nbib Format: NLM
A New Reporting System for Diagnosis of Hepatocellular Carcinoma in Chronic Hepatitis B With Clinical and Gadoxetic Acid-Enhanced MRI Features.

Journal of magnetic resonance imaging : JMRI

Hwang SH, Hong SB, Han K, Seo N, Choi JY, Lee JH, Park S, Lim YS, Kim DY, Kim SY, Park MS.
PMID: 34668595
J Magn Reson Imaging. 2021 Oct 20; doi: 10.1002/jmri.27962. Epub 2021 Oct 20.

BACKGROUND: Current major guidelines for diagnosis of hepatocellular carcinoma (HCC) based on imaging findings are different from each other and do not include clinical risk factors as a diagnostic criteria.PURPOSE: To developed and validated a new diagnostic score system...

Cite
Hwang SH, Hong SB, Han K, et al. A New Reporting System for Diagnosis of Hepatocellular Carcinoma in Chronic Hepatitis B With Clinical and Gadoxetic Acid-Enhanced MRI Features. J Magn Reson Imaging. 2021;doi: 10.1002/jmri.27962.
Hwang, S. H., Hong, S. B., Han, K., Seo, N., Choi, J. Y., Lee, J. H., Park, S., Lim, Y. S., Kim, D. Y., Kim, S. Y., & Park, M. S. (2021). A New Reporting System for Diagnosis of Hepatocellular Carcinoma in Chronic Hepatitis B With Clinical and Gadoxetic Acid-Enhanced MRI Features. Journal of magnetic resonance imaging : JMRI, . https://doi.org/10.1002/jmri.27962
Hwang, Shin Hye, et al. "A New Reporting System for Diagnosis of Hepatocellular Carcinoma in Chronic Hepatitis B With Clinical and Gadoxetic Acid-Enhanced MRI Features." Journal of magnetic resonance imaging : JMRI vol. (2021). doi: https://doi.org/10.1002/jmri.27962
Hwang SH, Hong SB, Han K, Seo N, Choi JY, Lee JH, Park S, Lim YS, Kim DY, Kim SY, Park MS. A New Reporting System for Diagnosis of Hepatocellular Carcinoma in Chronic Hepatitis B With Clinical and Gadoxetic Acid-Enhanced MRI Features. J Magn Reson Imaging. 2021 Oct 20; doi: 10.1002/jmri.27962. Epub 2021 Oct 20. PMID: 34668595.
Copy Download .nbib Format: NLM
Myocardial T1 mapping and determination of partition coefficients at 3 tesla: comparison between gadobenate dimeglumine and gadofosveset trisodium.

Radiologia brasileira

Nacif MS, Raman FS, Gai N, Jones J, van der Geest RJ, T Sibley C, Liu S, David AB.
PMID: 29559761
Radiol Bras. 2018 Jan-Feb;51(1):13-19. doi: 10.1590/0100-3984.2016.0071.

OBJECTIVE: To compare an albumin-bound gadolinium chelate (gadofosveset trisodium) and an extracellular contrast agent (gadobenate dimeglumine), in terms of their effects on myocardial longitudinal (T1) relaxation time and partition coefficient.MATERIALS AND METHODS: Study subjects underwent two imaging sessions for...

Cite
Nacif MS, Raman FS, Gai N, et al. Myocardial T1 mapping and determination of partition coefficients at 3 tesla: comparison between gadobenate dimeglumine and gadofosveset trisodium. Radiol Bras. 2018;51(1):13-19doi: 10.1590/0100-3984.2016.0071.
Nacif, M. S., Raman, F. S., Gai, N., Jones, J., van der Geest, R. J., T Sibley, C., Liu, S., & David, A. B. (2018). Myocardial T1 mapping and determination of partition coefficients at 3 tesla: comparison between gadobenate dimeglumine and gadofosveset trisodium. Radiologia brasileira, 51(1), 13-19. https://doi.org/10.1590/0100-3984.2016.0071
Nacif, Marcelo Souto, et al. "Myocardial T1 mapping and determination of partition coefficients at 3 tesla: comparison between gadobenate dimeglumine and gadofosveset trisodium." Radiologia brasileira vol. 51,1 (2018): 13-19. doi: https://doi.org/10.1590/0100-3984.2016.0071
Nacif MS, Raman FS, Gai N, Jones J, van der Geest RJ, T Sibley C, Liu S, David AB. Myocardial T1 mapping and determination of partition coefficients at 3 tesla: comparison between gadobenate dimeglumine and gadofosveset trisodium. Radiol Bras. 2018 Jan-Feb;51(1):13-19. doi: 10.1590/0100-3984.2016.0071. PMID: 29559761; PMCID: PMC5846320.
Copy Download .nbib Format: NLM
The Efficacy of One Molar Contrast Material in the Evaluation of Breast Lesions with MR Imaging.

Polish journal of radiology

Toprak N, Unal O, Avcu S.
PMID: 26405464
Pol J Radiol. 2015 Aug 29;80:401-10. doi: 10.12659/PJR.894863. eCollection 2015.

BACKGROUND: To investigate the efficacy of 1 molar (containing 1 mol/mL gadobutrol) contrast material in the differentiation of malignant and benign breast lesions with MRI.MATERIAL/METHODS: Thirty-seven women (age range: 22-77 years, mean: 43.7 years) with 76 breast lesions were...

Cite
Toprak N, Unal O, Avcu S. The Efficacy of One Molar Contrast Material in the Evaluation of Breast Lesions with MR Imaging. Pol J Radiol. 2015;80:401-10doi: 10.12659/PJR.894863.
Toprak, N., Unal, O., & Avcu, S. (2015). The Efficacy of One Molar Contrast Material in the Evaluation of Breast Lesions with MR Imaging. Polish journal of radiology, 80401-10. https://doi.org/10.12659/PJR.894863
Toprak, Nursen, et al. "The Efficacy of One Molar Contrast Material in the Evaluation of Breast Lesions with MR Imaging." Polish journal of radiology vol. 80 (2015): 401-10. doi: https://doi.org/10.12659/PJR.894863
Toprak N, Unal O, Avcu S. The Efficacy of One Molar Contrast Material in the Evaluation of Breast Lesions with MR Imaging. Pol J Radiol. 2015 Aug 29;80:401-10. doi: 10.12659/PJR.894863. eCollection 2015. PMID: 26405464; PMCID: PMC4557414.
Copy Download .nbib Format: NLM
Breast ductal carcinoma in situ: morphologic and kinetic MRI findings.

Iranian journal of radiology : a quarterly journal published by the Iranian Radiological Society

Nadrljanski MM, Marković BB, Milošević ZČ.
PMID: 24046788
Iran J Radiol. 2013 Jun;10(2):99-102. doi: 10.5812/iranjradiol.4876. Epub 2013 May 20.

BACKGROUND: Adequate diagnosis of ductal carcinoma in situ (DCIS) could lead to efficacious treatment. Due to the fact that DCIS lesions can progress to invasive carcinomas and that the sensitivity of the standard examination - mammography - is between...

Cite
Nadrljanski MM, Marković BB, Milošević ZČ. Breast ductal carcinoma in situ: morphologic and kinetic MRI findings. Iran J Radiol. 2013;10(2):99-102doi: 10.5812/iranjradiol.4876.
Nadrljanski, M. M., Marković, B. B., & Milošević, Z. �. �. (2013). Breast ductal carcinoma in situ: morphologic and kinetic MRI findings. Iranian journal of radiology : a quarterly journal published by the Iranian Radiological Society, 10(2), 99-102. https://doi.org/10.5812/iranjradiol.4876
Nadrljanski, Mirjan M, et al. "Breast ductal carcinoma in situ: morphologic and kinetic MRI findings." Iranian journal of radiology : a quarterly journal published by the Iranian Radiological Society vol. 10,2 (2013): 99-102. doi: https://doi.org/10.5812/iranjradiol.4876
Nadrljanski MM, Marković BB, Milošević ZČ. Breast ductal carcinoma in situ: morphologic and kinetic MRI findings. Iran J Radiol. 2013 Jun;10(2):99-102. doi: 10.5812/iranjradiol.4876. Epub 2013 May 20. PMID: 24046788; PMCID: PMC3767018.
Copy Download .nbib Format: NLM
A feasibility study evaluating the relationship between dose and focal liver reaction in stereotactic ablative radiotherapy for liver cancer based on intensity change of Gd-EOB-DTPA-enhanced magnetic resonance images.

Radiation oncology journal

Jung SH, Yu JI, Park HC, Lim DH, Han Y.
PMID: 27104169
Radiat Oncol J. 2016 Mar;34(1):64-75. doi: 10.3857/roj.2016.34.1.64. Epub 2016 Mar 30.

PURPOSE: In order to evaluate the relationship between the dose to the liver parenchyma and focal liver reaction (FLR) after stereotactic ablative body radiotherapy (SABR), we suggest a novel method using a three-dimensional dose distribution and change in signal...

Cite
Jung SH, Yu JI, Park HC, et al. A feasibility study evaluating the relationship between dose and focal liver reaction in stereotactic ablative radiotherapy for liver cancer based on intensity change of Gd-EOB-DTPA-enhanced magnetic resonance images. Radiat Oncol J. 2016;34(1):64-75doi: 10.3857/roj.2016.34.1.64.
Jung, S. H., Yu, J. I., Park, H. C., Lim, D. H., & Han, Y. (2016). A feasibility study evaluating the relationship between dose and focal liver reaction in stereotactic ablative radiotherapy for liver cancer based on intensity change of Gd-EOB-DTPA-enhanced magnetic resonance images. Radiation oncology journal, 34(1), 64-75. https://doi.org/10.3857/roj.2016.34.1.64
Jung, Sang Hoon, et al. "A feasibility study evaluating the relationship between dose and focal liver reaction in stereotactic ablative radiotherapy for liver cancer based on intensity change of Gd-EOB-DTPA-enhanced magnetic resonance images." Radiation oncology journal vol. 34,1 (2016): 64-75. doi: https://doi.org/10.3857/roj.2016.34.1.64
Jung SH, Yu JI, Park HC, Lim DH, Han Y. A feasibility study evaluating the relationship between dose and focal liver reaction in stereotactic ablative radiotherapy for liver cancer based on intensity change of Gd-EOB-DTPA-enhanced magnetic resonance images. Radiat Oncol J. 2016 Mar;34(1):64-75. doi: 10.3857/roj.2016.34.1.64. Epub 2016 Mar 30. PMID: 27104169; PMCID: PMC4831971.
Copy Download .nbib Format: NLM
Unusual Use of Gd-EOB-DTPA in MRCP in Order to Reveal the Source of Bile Leakage in a Patient with Neuroendocrine Tumor - Case Report.

Polish journal of radiology

Mazur R, Pawluś A, Szymańska K, Patyk M, Otlewska A, Międzybrodzki K, Sokołowska-Dąbek D, Kubicka E, Zaleska-Dorobisz U.
PMID: 27920840
Pol J Radiol. 2016 Nov 14;81:536-539. doi: 10.12659/PJR.898781. eCollection 2016.

BACKGROUND: MRCP is the method of choice in diagnosing pathologies of the biliary system. One of them is bile fistulae. They are uncommon but tend to cause many diagnostic problems. The possible way to improve MRCP is using it...

Cite
Mazur R, Pawluś A, Szymańska K, et al. Unusual Use of Gd-EOB-DTPA in MRCP in Order to Reveal the Source of Bile Leakage in a Patient with Neuroendocrine Tumor - Case Report. Pol J Radiol. 2016;81:536-539doi: 10.12659/PJR.898781.
Mazur, R., Pawluś, A., Szymańska, K., Patyk, M., Otlewska, A., Międzybrodzki, K., Sokołowska-Dąbek, D., Kubicka, E., & Zaleska-Dorobisz, U. (2016). Unusual Use of Gd-EOB-DTPA in MRCP in Order to Reveal the Source of Bile Leakage in a Patient with Neuroendocrine Tumor - Case Report. Polish journal of radiology, 81536-539. https://doi.org/10.12659/PJR.898781
Mazur, Rafał, et al. "Unusual Use of Gd-EOB-DTPA in MRCP in Order to Reveal the Source of Bile Leakage in a Patient with Neuroendocrine Tumor - Case Report." Polish journal of radiology vol. 81 (2016): 536-539. doi: https://doi.org/10.12659/PJR.898781
Mazur R, Pawluś A, Szymańska K, Patyk M, Otlewska A, Międzybrodzki K, Sokołowska-Dąbek D, Kubicka E, Zaleska-Dorobisz U. Unusual Use of Gd-EOB-DTPA in MRCP in Order to Reveal the Source of Bile Leakage in a Patient with Neuroendocrine Tumor - Case Report. Pol J Radiol. 2016 Nov 14;81:536-539. doi: 10.12659/PJR.898781. eCollection 2016. PMID: 27920840; PMCID: PMC5119684.
Copy Download .nbib Format: NLM
Gadolinium-DTPA amphiphile nanoassemblies: agents for magnetic resonance imaging and neutron capture therapy.

Biomaterials science

Moghaddam MJ, de Campo L, Hirabayashi M, Bean PA, Waddington LJ, Scoble JA, Coia G, Drummond CJ.
PMID: 32481823
Biomater Sci. 2014 Jun 07;2(6):924-935. doi: 10.1039/c3bm60235d. Epub 2014 Feb 17.

Engineering biocompatible and physiologically stable nanoscaled therapeutics and imaging agents with the ability to target tumor tissue is a key challenge for the advancement of cancer therapeutics and diagnostic imaging. Here, we present chelating amphiphiles with the capacity to...

Cite
Moghaddam MJ, de Campo L, Hirabayashi M, et al. Gadolinium-DTPA amphiphile nanoassemblies: agents for magnetic resonance imaging and neutron capture therapy. Biomater Sci. 2014;2(6):924-935doi: 10.1039/c3bm60235d.
Moghaddam, M. J., de Campo, L., Hirabayashi, M., Bean, P. A., Waddington, L. J., Scoble, J. A., Coia, G., & Drummond, C. J. (2014). Gadolinium-DTPA amphiphile nanoassemblies: agents for magnetic resonance imaging and neutron capture therapy. Biomaterials science, 2(6), 924-935. https://doi.org/10.1039/c3bm60235d
Moghaddam, Minoo J, et al. "Gadolinium-DTPA amphiphile nanoassemblies: agents for magnetic resonance imaging and neutron capture therapy." Biomaterials science vol. 2,6 (2014): 924-935. doi: https://doi.org/10.1039/c3bm60235d
Moghaddam MJ, de Campo L, Hirabayashi M, Bean PA, Waddington LJ, Scoble JA, Coia G, Drummond CJ. Gadolinium-DTPA amphiphile nanoassemblies: agents for magnetic resonance imaging and neutron capture therapy. Biomater Sci. 2014 Jun 07;2(6):924-935. doi: 10.1039/c3bm60235d. Epub 2014 Feb 17. PMID: 32481823.
Copy Download .nbib Format: NLM
Intramedullary gadolinium-DTPA enhancement in a patient with cervical spondylotic myelopathy and an associated vascular lesion. Case report.

Neurosurgical focus

Morimoto T, Yamada T, Nagata K, Matsuyama T, Sakaki T.
PMID: 15096029
Neurosurg Focus. 1996 Dec 15;1(6):e3.

Intramedullary enhancement of the cervical spinal cord is rare in chronic compression disease. An accompanying vascular lesion should be considered in such a case. A 59-year-old man presented with severe cervical spondylotic myelopathy. Gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) enhanced magnetic...

Cite
Morimoto T, Yamada T, Nagata K, et al. Intramedullary gadolinium-DTPA enhancement in a patient with cervical spondylotic myelopathy and an associated vascular lesion. Case report. Neurosurg Focus. 1996;1(6):e3
Morimoto, T., Yamada, T., Nagata, K., Matsuyama, T., & Sakaki, T. (1996). Intramedullary gadolinium-DTPA enhancement in a patient with cervical spondylotic myelopathy and an associated vascular lesion. Case report. Neurosurgical focus, 1(6), e3.
Morimoto, T, et al. "Intramedullary gadolinium-DTPA enhancement in a patient with cervical spondylotic myelopathy and an associated vascular lesion. Case report." Neurosurgical focus vol. 1,6 (1996): e3.
Morimoto T, Yamada T, Nagata K, Matsuyama T, Sakaki T. Intramedullary gadolinium-DTPA enhancement in a patient with cervical spondylotic myelopathy and an associated vascular lesion. Case report. Neurosurg Focus. 1996 Dec 15;1(6):e3. PMID: 15096029.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 21 entries